Clinical trial
A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT00028899 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Dose Finding Study of the Safety of Gemtuzumab Ozogamicin Combined With Conventional Chemotherapy for Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Lead sponsor
- Children's Oncology Group
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- March 31, 2012
- Enrollment
- 47 (actual)
- Sites
- 76
Conditions
As the registry lists them; a condition with its own page is linked.